Unlocking the Mystery of Alzheimers Disease: Controversies over Hypotheses

Struggling Search for the Best Disease-modifying Approach

USD 1,500

* Required Fields

USD 1,500

PAY BY INVOICE

Be the first to review this product

This market insight compares and contrasts the various hypotheses postulated based on Alzheimer's disease-modifying drug candidates under investigation in clinical trials. The mechanisms based on the two hallmark features of the disease, namely beta-amyloid and tau protein, have been analysed in detail. A brief overview of the other range of disease targets have also been provided.

Table of Contents

Unlocking the Mystery of Alzheimer's Disease: Controversies over HypothesesAlzheimer's Disease - The Twisted TaleIntroductionUnlocking the Mystery of Alzheimer's Disease: Are We on the Right Track?Conclusion




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.